These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23975613)
1. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. Bell RJ; Robinson PJ; Nazeem F; Panjari M; Fradkin P; Schwarz M; Davis SR J Cancer Surviv; 2014 Mar; 8(1):1-8. PubMed ID: 23975613 [TBL] [Abstract][Full Text] [Related]
2. Consistency of breast and arm symptoms during the first two years after breast cancer surgery. Wennman-Larsen A; Petersson LM; Saboonchi F; Alexanderson K; Vaez M Oncol Nurs Forum; 2015 Mar; 42(2):145-55. PubMed ID: 25806881 [TBL] [Abstract][Full Text] [Related]
4. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Coen JJ; Taghian AG; Kachnic LA; Assaad SI; Powell SN Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1209-15. PubMed ID: 12654429 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications]. Gross E; Hannoun-Levi JM; Rouanet P; Houvenaeghel G; Teissier E; Ellis S; Resbeut M; Tallet A; Vaini Cowen V; Azria D; Cowen D Cancer Radiother; 2010 Dec; 14(8):704-10. PubMed ID: 20674442 [TBL] [Abstract][Full Text] [Related]
6. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma. Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122 [TBL] [Abstract][Full Text] [Related]
7. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Rebegea L; Firescu D; Dumitru M; Anghel R Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313 [TBL] [Abstract][Full Text] [Related]
8. [Adjuvant treatment of operable breast cancer]. Khosravi Shahi P; Izarzugaza Perón Y; Encinas García S; Díaz Muñoz de la Espada VM; Pérez Manga G An Med Interna; 2008 Jan; 25(1):36-40. PubMed ID: 18377195 [TBL] [Abstract][Full Text] [Related]
9. A Morbidity Screening Tool for identifying fatigue, pain, upper limb dysfunction and lymphedema after breast cancer treatment: a validity study. Bulley C; Coutts F; Blyth C; Jack W; Chetty U; Barber M; Tan CW Eur J Oncol Nurs; 2014 Apr; 18(2):218-27. PubMed ID: 24246445 [TBL] [Abstract][Full Text] [Related]
10. Survivorship and complications of treatment in breast cancer. Mrozek E; Shapiro CL Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992 [TBL] [Abstract][Full Text] [Related]
11. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401 [TBL] [Abstract][Full Text] [Related]
12. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Zammit C; Yelland A; Deutsch G Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708 [No Abstract] [Full Text] [Related]
14. Self-reported arm-lymphedema and functional impairment after breast cancer treatment--a nationwide study of prevalence and associated factors. Gärtner R; Jensen MB; Kronborg L; Ewertz M; Kehlet H; Kroman N Breast; 2010 Dec; 19(6):506-15. PubMed ID: 20561790 [TBL] [Abstract][Full Text] [Related]
15. Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer. Kim M; Shin KH; Jung SY; Lee S; Kang HS; Lee ES; Chung SH; Kim YJ; Kim TH; Cho KH Cancer Res Treat; 2016 Oct; 48(4):1330-1337. PubMed ID: 26875199 [TBL] [Abstract][Full Text] [Related]
16. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Cunnick GH; Mokbel K Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550707 [No Abstract] [Full Text] [Related]
17. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Baroni G; Pedotti A; Orecchia R Lancet; 2003 Oct; 362(9390):1155; author reply 1155-6. PubMed ID: 14550709 [No Abstract] [Full Text] [Related]
18. [Breast carcinoma in accessory gland: a case report]. Sivelli R; Del Rio P; Arcuri MF; Corcione L G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967 [TBL] [Abstract][Full Text] [Related]
19. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients. Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935 [TBL] [Abstract][Full Text] [Related]
20. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. Ahmed RL; Prizment A; Lazovich D; Schmitz KH; Folsom AR J Clin Oncol; 2008 Dec; 26(35):5689-96. PubMed ID: 19001331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]